Qube Research & Technologies (QRT)
KZIA

Qube Research & Technologies (QRT)’s Kazia Therapeutics KZIA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,608
Closed -$78.9K – 3807
2026
Q1 		$78.9K Buy
+10,608
New +$73.8K ﹤0.01% 3108

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KZIA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Kazia Therapeutics (KZIA) in Q2 2026, closing a stake of 10,608 shares — an estimated $78.9K sold.

Qube Research & Technologies (QRT) first reported a position in KZIA in Q1 2026 and held it in 1 quarter. The position peaked at $78.9K in Q1 2026. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Kazia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,608 Kazia Therapeutics shares in Q2 2026, an estimated $78.9K.
  • Qube Research & Technologies (QRT) first reported a position in Kazia Therapeutics in Q1 2026 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Kazia Therapeutics position peaked at $78.9K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.